Results 181 to 190 of about 406,045 (339)

461 Circadian control of the tumor immune microenvironment determines immune checkpoint inhibitor efficacy [PDF]

Jake Lichterman, Tarun Srinivasan, Ruheng Wang, Chaitanya Dende, Mitchell S. von Itzstein, Jialiang Liu, Jorge H Ramírez, Wenling Li, Laura Coughlin, Nicole Poulides, Parastoo Sabaeifard, Tian Zhang, Hans J. Hammers, Xin Li, Bret M. Evers, Xiaowei Zhan, David E. Gerber, Lora V. Hooper, Andrew Y. Koh   +18 more
openalex   +1 more source

Data from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

, 2023
Chiara Ratti, Laura Botti, Valeria Cancila, Silvia Galvan, Ilaria Torselli, Cecilia Garofalo, Maria Cristina Manara, Lucia Bongiovanni, Cesare Valenti, Alessia Burocchi, Mariella Parenza, Barbara Cappetti, Sabina Sangaletti, Claudio Tripodo, Katia Scotlandi, Mario P. Colombo, Claudia Chiodoni   +16 more
openalex   +1 more source

Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity

Critical Care Medicine, 2019
Karthik, Suresh, Franco, D'Alessio
openaire   +3 more sources

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

Advanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong, Yuhang Xie, Zhijie Weng, Yongzhi Wu, Longjiang Li, Bo Li   +5 more
wiley   +1 more source

Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis. [PDF]

Arthritis Rheumatol
Kim ST, Bass AR.
europepmc   +1 more source

eLife Assessment: Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer

Ching-Hao X Wang
openalex   +1 more source

Table S1 from Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

, 2023
Chiara Ratti, Laura Botti, Valeria Cancila, Silvia Galvan, Ilaria Torselli, Cecilia Garofalo, Maria Cristina Manara, Lucia Bongiovanni, Cesare Valenti, Alessia Burocchi, Mariella Parenza, Barbara Cappetti, Sabina Sangaletti, Claudio Tripodo, Katia Scotlandi, Mario P. Colombo, Claudia Chiodoni   +16 more
openalex   +1 more source

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer

Advanced Science, EarlyView.
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley   +1 more source

Immune checkpoint TIM-3 in tumor immunotherapy. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Ma S, Zhu M, Ma C, Li C.
europepmc   +1 more source

Supplementary Data from Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade

, 2023
Yu Saida, Jeffrey Brender, Kazutoshi Yamamoto, James B. Mitchell, Murali C. Krishna, Shun Kishimoto   +5 more
openalex   +1 more source